[Correspondence] Call to Enhance Civilian and Military Blood Preparedness

Why It Matters

Adequate blood supplies are a strategic health‑system asset that can save lives in both military operations and civilian emergencies. The recommendation forces governments to align defence planning with public‑health logistics, addressing a critical supply gap.

Key Takeaways

• NATO urges joint civilian‑military blood surge planning.
• Current global supply lags demand by over 30 million units.
• Dried plasma production falls short of NATO's strategic needs.
• Modeling must integrate regional disease burden and infrastructure.
• Standardized data exchange critical for real‑time logistics.

Pulse Analysis

Recent Russian airspace incursions across the Baltic and Eastern European NATO members have revived concerns that large‑scale combat could erupt in Europe. In that climate, the NATO Blood Panel’s February 2026 meeting in Brussels produced a stark reminder that blood products are a strategic capability as vital as ammunition or fuel. Whole blood, especially low‑titer group O, remains the preferred resuscitation fluid for severe haemorrhage, while pre‑hospital plasma can cut mortality when transport times exceed twenty minutes. The panel warns that without coordinated civilian‑military preparedness, surge demand could overwhelm existing health‑system capacities.

3 million were available, a shortfall that would be magnified in a mass‑casualty scenario. NATO policy permits cold‑stored whole blood for up to 35 days, yet donor frequency limits early stockpiling. More troubling is the scarcity of dried plasma—approximately 100 000 units produced annually by NATO nations versus the ten‑million units generated by the Allies in World War II. Expanding dried‑plasma capacity through government incentives and public‑private partnerships is essential to bridge this gap.

To translate the panel’s recommendations into action, governments must fund robust modeling that incorporates regional disease burden, health‑care infrastructure, and transfusion practices, producing realistic surge estimates. Standardising nomenclature, screening protocols, and secure data exchange will enable real‑time visibility across civilian and military inventories, while protecting supply chains from cyber and physical threats. Investment in universal blood products with extended shelf life and scalable production facilities will further enhance resilience. By embedding blood logistics into national defence planning, NATO members can safeguard both combat troops and civilian populations, reducing preventable deaths in future crises.